CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $102,000 | -30.1% | 16,000 | +14.3% | 0.00% | 0.0% |
| Q4 2019 | $146,000 | +105.6% | 14,000 | -22.7% | 0.00% | +100.0% |
| Q3 2019 | $71,000 | -98.9% | 18,100 | -74.5% | 0.00% | -99.0% |
| Q3 2015 | $6,523,000 | +1250.5% | 70,937 | +1189.8% | 0.19% | +1500.0% |
| Q2 2015 | $483,000 | – | 5,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |